Concepedia

Ted J. Kottom

TJ

Statistics

Publications

2

Citations

1K

H-Index

2

Active since

2004

Affiliations

Mayo Clinic(Current)

Ted J. Kottom is an author at Mayo Clinic specializing in inflammatory signaling, progressive pulmonary fibrosis, and fibrosis.

Publications per year

2004–2004

2

Publications

2

Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis

Craig Daniels, Mark C. Wilkes, Maryanne Edens et al. · Journal of Clinical Investigation · 2004 · 525 citations · Full text

, , +16

Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis

Craig Daniels, Mark C. Wilkes, Maryanne Edens et al. · Journal of Clinical Investigation · 2004 · 486 citations · Full text

, , +16

1–2 of 2